The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD)

BACKGROUND: ADHD is currently defined as a cognitive/behavioral developmental disorder where all clinical criteria are behavioral. Overactivity, impulsiveness, and inattentiveness are presently regarded as the main clinical symptoms. There is no biological marker, but there is considerable evidence...

Descripción completa

Detalles Bibliográficos
Autor principal: Sagvolden, Terje
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764416/
https://www.ncbi.nlm.nih.gov/pubmed/17173664
http://dx.doi.org/10.1186/1744-9081-2-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764416/
https://www.ncbi.nlm.nih.gov/pubmed/17173664
http://dx.doi.org/10.1186/1744-9081-2-41

Ejemplares similares